ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0968

Neuropsychological Outcome of Children Born to Women with Systemic Sclerosis: Assessment Through a Self-administered Multidisciplinary Questionnaire in a Monocentric Cohort

Eleonora Pedretti1, Laura Andreoli1, Liala Moschetti1, Cecilia Nalli1, Anna Molinaro2, Jessica Galli2, Elisa Fazzi2, Franco Franceschini1, Angela Tincani3, Paolo Airò4 and Maria Grazia Lazzaroni1, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, 2Unit of Child and Adolescent Neuropsychiatry, ASST Spedali Civili and University of Brescia, Brescia, Italy, 3Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Gussago, Italy, 4Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy

Meeting: ACR Convergence 2022

Keywords: gender, neuropsychiatric disorders, quality of life, Systemic sclerosis, Women's health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Reproductive Issues in Rheumatic Disorders Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: In the last years, the rate of successful pregnancies has significantly increased in Systemic Sclerosis (SSc)1 women. However, the long-term outcome of their children remains an unexplored issue. Our aim is to evaluate the neuropsychiatric (NP) outcome of children born to SSc mothers.

Methods: An ad-hoc questionnaire, regarding different aspects of child’s neurodevelopment (ND) (3 sections: childhood [0-5 years]; scholar age [6-11 years]; adolescence [12-18 years]), was created and administered to female SSc patients (ACR/EULAR 2013 criteria) attending our outpatient clinic during 2021 and who had at least 1 child. Children’s NP characteristics were compared between 3 subgroups: A) born >10 years before SSc diagnosis; B) born £10 years before SSc diagnosis; C) born after SSc diagnosis. Results below are expressed as number/total number of answers collected for each question.

Results: 100 SSc women reported 189 pregnancies: 152 resulted in 154 live births (2 twin pregnancies, M/F=85/69). Deliveries occurred at a median of 39 (36-40) weeks of gestation: 28% of preterm births and 6% of severe preterm births (< 34 weeks of gestation). At least one NP alteration was reported in 42/119 (35%) subjects, more frequently in group B (57%), as compared to group A (32%, p:0.07) and group C (28%, p:0.09) (Figure 1). Sleep irregularities were the most frequently reported disorder (n=15). Comparisons between the 3 subgroups for each NP outcome are shown in Table 1: overall, a higher rate of NP alterations were reported in children of group B. A higher rate (12%) of severe preterm birth was observed in babies born in group C. In addition, SSc mothers declared that 7/123 (6%) children underwent a NP evaluation leading to a diagnosis in 3 cases: 1 cognitive delay, 1 learning disability (LD) and 1 autism spectrum disorder (ASD). These children were born 1 and 5 years before and 3 years after SSc diagnosis, respectively.

Conclusion: Children born to SSc mothers had a frequency of major NP alterations (cognitive delay, LD, ASD) similar to general pediatric population2. A higher frequency of minor ND disorders, especially sleep irregularities, was observed in children within 10 years before maternal diagnosis, possibly suggesting an impact of maternal chronic disease on the relationship with child in the first years of life. To confirm these self-reported preliminary data, the extension of the study will consist in a NP specialistic evaluation proposed to the offspring of SSc mothers aged £18 years.

GILS (Gruppo Italiano Lotta Sclerodermia) is kindly acknowledged for supporting the study with a grant.

Supporting image 1

Figure 1. Frequency of children with at least one NP alteration according to the 3 age subgroups.

Supporting image 2

Table 1. Comparison of NP characteristics of the 154 children according to age subgroups: univariate analysis.
Results are presented as number/total number (%) of answers collected for each question. Variables were compared by Chi Squared/exact Fisher test. *p=0.03; °p=0.04; ^p=0.02.


Disclosures: E. Pedretti, None; L. Andreoli, GlaxoSmithKlein(GSK), Janssen, Novartis, UCB, Werfen; L. Moschetti, None; C. Nalli, None; A. Molinaro, None; J. Galli, None; E. Fazzi, None; F. Franceschini, None; A. Tincani, GlaxoSmithKlein(GSK), UCB; P. Airò, Bristol-Myers-Squibb, Boehringer Ingelheim, Roche, Jannsen, CSL Behring; M. Lazzaroni, None.

To cite this abstract in AMA style:

Pedretti E, Andreoli L, Moschetti L, Nalli C, Molinaro A, Galli J, Fazzi E, Franceschini F, Tincani A, Airò P, Lazzaroni M. Neuropsychological Outcome of Children Born to Women with Systemic Sclerosis: Assessment Through a Self-administered Multidisciplinary Questionnaire in a Monocentric Cohort [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/neuropsychological-outcome-of-children-born-to-women-with-systemic-sclerosis-assessment-through-a-self-administered-multidisciplinary-questionnaire-in-a-monocentric-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neuropsychological-outcome-of-children-born-to-women-with-systemic-sclerosis-assessment-through-a-self-administered-multidisciplinary-questionnaire-in-a-monocentric-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology